Evidence map›Paper›PMID 32718222›Full record

ReviewUnited European gastroenterology journal2020

Alcoholic hepatitis: Towards an era of personalised management.

Delphine Degré, Line C Ntandja Wandji, Christophe Moreno, Alexandre Louvet

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in United European gastroenterology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Severe alcoholic hepatitis: Jumping from the frying pan into the fire.United European gastroenterology journal · 2021
    Article
  7. Hepatic injuries resulting from chronic alcohol abuse identified by forensics.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Delphine DegréDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Université Libre de Bruxelles, Brussels, Belgium.
Line C Ntandja WandjiService des maladies de l'appareil digestif, Université Lille Nord de France, Lille, France.
Christophe MorenoDepartment of Gastroenterology, Hepatopancreatology and Digestive Oncology, Université Libre de Bruxelles, Brussels, Belgium.
Alexandre LouvetService des maladies de l'appareil digestif, Université Lille Nord de France, Lille, France.
Université Libre de Bruxelles · BEUniversité Lille Nord de France · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcoholic hepatitis should be suspected in every patient with excessive chronic alcohol consumption and recent onset of jaundice. Diagnosis of alcoholic hepatitis is based on clinical and laboratory findings, and confirmed by a liver biopsy when available. Several scores are available to assess severity and prognosis of alcoholic hepatitis. The 1-month mortality of patients with severe alcoholic hepatitis, as defined by Maddrey's discriminant function, is 20-30%. Therefore, severe alcoholic hepatitis should be treated with a 28-day course of oral prednisolone after systematic screening for infection. In this review, we discuss diagnosis of alcoholic hepatitis, the different scores to assess severity of the disease, indications for corticosteroid therapy and alternative therapeutic options for non-responders to medical therapy.

Indexed as

AlcoholismBiopsyClinical Decision-MakingEnd Stage Liver DiseaseGlucocorticoidsHepatitis, AlcoholicHumansLiverLiver Function TestsLiver TransplantationMaleMiddle AgedPatient SelectionPrognosisSeverity of Illness IndexTreatment OutcomeGlucocorticoidsAlcoholic hepatitisdisease severityLille scoreliver transplantationprednisolone

Identifiers

PMID32718222
PMCPMC7724541
OpenAlexW3046160999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.